Here are seven orthopedic and spine devicemakers that have raised series A and series C funding this year, totaling $283.5 million:
1. Discure Technologies raised $16 million in Series A funding for the development of a bioelectronic implantable device for the treatment of degenerative disc disease.
2. Knee implant maker Moximed closed on a round of stock financing for up to $91 million. The funding round includes $61 million and an option to acquire an additional $30 million. The investment round was led by Elevage Medical Technologies.
3. Orthopedic implant company restor3d raised $70 million in financing to support the company's launch of 3D-printed implant systems and investments in new technologies. The devicemaker plans to introduce new patient-specific implant systems for total ankle and shoulder replacements.
4. Lenoss Medical closed an oversubscribed series A funding round of $4 million to help accelerate commercialization of its OsteoPearl spinal allograft.
5. Miach Orthopaedics, which is behind the Bridge-Enhanced ACL restoration implant, raised $20 million in series B financing. The funds will help the company's commercial expansion for the BEAR implant and clinical activities for it.
6. Spine devicemaker Carlsmed raised $52.5M in series C funding and will use the money to develop patient-specific cervical implants.
7. Synergy Spine Solutions, which focuses on cervical disc replacement devices, closed $30 million in series A financing that will go toward the company's investigational device exemption 2-level clinical trial. The trial will evaluate the disc at two contiguous levels compared to anterior cervical discectomy and fusion.